While potential Trump tariffs spark investor anxiety, a far more critical risk is unfolding in Asia. Are you prepared?

Whilst Zoom has made communicating with companies far more efficient, at NAOS we still believe that nothing beats a ...

We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

Australian investors have long favoured traditional assets, like stocks, bonds, and brick-and-mortar property.

And why Lazard Asset Management's June-Yon Kim believes investors can expect improving earnings growth from Japanese ...

There may not be industry-wide reporting just yet but transparency around returns and fees are finally coming through in ...